196 related articles for article (PubMed ID: 11940291)
21. Implications of recurrent ischemia after reperfusion therapy in acute myocardial infarction: a comparison of thrombolytic therapy and primary angioplasty.
Stone GW; Grines CL; Browne KF; Marco J; Rothbaum D; O'Keefe J; Hartzler GO; Overlie P; Donohue B; Chelliah N
J Am Coll Cardiol; 1995 Jul; 26(1):66-72. PubMed ID: 7797777
[TBL] [Abstract][Full Text] [Related]
22. Clinical experience with primary percutaneous transluminal coronary angioplasty compared with alteplase (recombinant tissue-type plasminogen activator) in patients with acute myocardial infarction: a report from the Second National Registry of Myocardial Infarction (NRMI-2).
Tiefenbrunn AJ; Chandra NC; French WJ; Gore JM; Rogers WJ
J Am Coll Cardiol; 1998 May; 31(6):1240-5. PubMed ID: 9581714
[TBL] [Abstract][Full Text] [Related]
23. Angiographic and long-term outcomes of "rescue" stenting versus PTCA in failed thrombolysis in acute myocardial infarction.
Tadros GM; Islam MA; Mirza A; Blankenship JC; Iliadis EA
Angiology; 2004; 55(2):169-76. PubMed ID: 15026872
[TBL] [Abstract][Full Text] [Related]
24. One-year clinical outcomes and relative costs of primary infarct artery stenting versus angioplasty following systemic thrombolysis for acute myocardial infarction.
Rocha-Singh KJ; McShane KJ; Ligon R; Sung CH
Catheter Cardiovasc Interv; 2000 Feb; 49(2):135-41. PubMed ID: 10642759
[TBL] [Abstract][Full Text] [Related]
25. Usefulness of late coronary thrombolysis (recombinant tissue-type plasminogen activator) in preserving left ventricular function in acute myocardial infarction.
Villari B; Piscione F; Bonaduce D; Golino P; Lanzillo T; Condorelli M; Chiariello M
Am J Cardiol; 1990 Dec; 66(19):1281-6. PubMed ID: 2123072
[TBL] [Abstract][Full Text] [Related]
26. Six- and twelve-month follow-up of the phase I Thrombolysis in Myocardial Infarction (TIMI) trial.
Dalen JE; Gore JM; Braunwald E; Borer J; Goldberg RJ; Passamani ER; Forman S; Knatterud G
Am J Cardiol; 1988 Aug; 62(4):179-85. PubMed ID: 3135737
[TBL] [Abstract][Full Text] [Related]
27. Stenting versus thrombolysis in acute myocardial infarction trial (STAT).
Le May MR; Labinaz M; Davies RF; Marquis JF; Laramée LA; O'Brien ER; Williams WL; Beanlands RS; Nichol G; Higginson LA
J Am Coll Cardiol; 2001 Mar; 37(4):985-91. PubMed ID: 11263625
[TBL] [Abstract][Full Text] [Related]
28. Effect of heparin on coronary arterial patency after thrombolysis with tissue plasminogen activator in acute myocardial infarction.
Bleich SD; Nichols TC; Schumacher RR; Cooke DH; Tate DA; Teichman SL
Am J Cardiol; 1990 Dec; 66(20):1412-7. PubMed ID: 2123602
[TBL] [Abstract][Full Text] [Related]
29. Intravenous recombinant tissue-type plasminogen activator in acute myocardial infarction.
Gao R; Chen J; Kou W; Yao K; Xu Y; Lu Z; Yu Q; Tao P; Ma J; Zhu J
Chin Med Sci J; 1991 Sep; 6(3):132-5. PubMed ID: 1793874
[TBL] [Abstract][Full Text] [Related]
30. Combined tissue-type plasminogen activator and prostacyclin therapy for acute myocardial infarction. Thrombolysis and Angioplasty in Myocardial Infarction (TAMI) 4 Study Group.
Topol EJ; Ellis SG; Califf RM; George BS; Stump DC; Bates ER; Nabel EG; Walton JA; Candela RJ; Lee KL
J Am Coll Cardiol; 1989 Oct; 14(4):877-84. PubMed ID: 2477426
[TBL] [Abstract][Full Text] [Related]
31. Outcome of patients with diabetes mellitus and acute myocardial infarction treated with thrombolytic agents. The Thrombolysis and Angioplasty in Myocardial Infarction (TAMI) Study Group.
Granger CB; Califf RM; Young S; Candela R; Samaha J; Worley S; Kereiakes DJ; Topol EJ
J Am Coll Cardiol; 1993 Mar; 21(4):920-5. PubMed ID: 8450161
[TBL] [Abstract][Full Text] [Related]
32. Comparison of protective effects of preinfarction angina pectoris in acute myocardial infarction treated by thrombolysis versus by primary coronary angioplasty with stenting.
Tomoda H; Aoki N
Am J Cardiol; 1999 Sep; 84(6):621-5. PubMed ID: 10498128
[TBL] [Abstract][Full Text] [Related]
33. Recurrent ischemia without warning. Analysis of risk factors for in-hospital ischemic events following successful thrombolysis with intravenous tissue plasminogen activator.
Ellis SG; Topol EJ; George BS; Kereiakes DJ; Debowey D; Sigmon KN; Pickel A; Lee KL; Califf RM
Circulation; 1989 Nov; 80(5):1159-65. PubMed ID: 2509102
[TBL] [Abstract][Full Text] [Related]
34. Impact of early accelerated dose tissue plasminogen activator on in-hospital patency of the infarcted vessel in patients with acute right ventricular infarction.
Giannitsis E; Potratz J; Wiegand U; Stierle U; Djonlagic H; Sheikhzadeh A
Heart; 1997 Jun; 77(6):512-6. PubMed ID: 9227293
[TBL] [Abstract][Full Text] [Related]
35. Predictors of in-hospital and 6-month outcome after acute myocardial infarction in the reperfusion era: the Primary Angioplasty in Myocardial Infarction (PAMI) trail.
Stone GW; Grines CL; Browne KF; Marco J; Rothbaum D; O'Keefe J; Hartzler GO; Overlie P; Donohue B; Chelliah N
J Am Coll Cardiol; 1995 Feb; 25(2):370-7. PubMed ID: 7829790
[TBL] [Abstract][Full Text] [Related]
36. Effectiveness and safety of a single intravenous bolus injection of tissue-type plasminogen activator in acute myocardial infarction. Bolus Dose-Escalation Study of Tissue-Type Plasminogen Activator (BEST) Investigators.
Hackett D; Andreotti F; Haider AW; Brunelli C; Shahi M; Fussell A; Buller N; Foale R; Lipkin D; Caponnetto S
Am J Cardiol; 1992 Jun; 69(17):1393-8. PubMed ID: 1590225
[TBL] [Abstract][Full Text] [Related]
37. Effects of time required for reperfusion (thrombolysis or angioplasty, or both) and location of acute myocardial infarction on left ventricular functional reserve capacity several months later.
Little T; Crenshaw M; Liberman HA; Battey LL; Warner R; Churchwell AL; Eisner RL; Morris DC; Patterson RE
Am J Cardiol; 1991 Apr; 67(9):797-805. PubMed ID: 1901437
[TBL] [Abstract][Full Text] [Related]
38. Combination thrombolytic therapy: a comparison of simultaneous and sequential regimens of tissue plasminogen activator and urokinase.
Morris JA; Muller DW; Topol EJ
Am Heart J; 1991 Aug; 122(2):375-80. PubMed ID: 1907086
[TBL] [Abstract][Full Text] [Related]
39. The importance of early patency after acute myocardial infarction.
Grover A; Rihal CS
Curr Opin Cardiol; 1995 Jul; 10(4):361-6. PubMed ID: 7549077
[TBL] [Abstract][Full Text] [Related]
40. Benefits of late coronary artery stenting in patients with acute myocardial infarction with and without thrombolytic therapy.
Hsieh IC; Chang HJ; Chern MS; Hung KC; Lin FC; Wu D
Chang Gung Med J; 2000 Dec; 23(12):738-46. PubMed ID: 11416894
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
